跳至主要内容
临床试验/NCT02212470
NCT02212470已完成4 期

Randomized Controlled Trial of Paclitaxel Drug-coated Balloons vs. Nitinol Stent for Femoropopliteal Obstructions - The PAVENST Trial

Instituto Dante Pazzanese de Cardiologia1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2014年7月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
85
试验地点
1
主要终点
Primary patency

研究概览

简要总结

The purpose of this study is to evaluate whether the results of drug eluting balloon are non-inferior to the Nitinol stent implantation in the femoropopliteal segment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients over 18 years with critical lower limb ischemia,
  • •Ruhtherford 3 or higher,
  • •with angiographic documentation of greater than 70% or occlusion in the superficial femoral artery,
  • •with a maximum extension of 10 cm stenosis.
  • •The popliteal artery and at least one leg artery must be patent.

排除标准

  • •Pregnancy,
  • •thrombophilia,
  • •coagulation disorders,
  • •presence of active or recent bleeding,
  • •severe allergy to iodinated contrast,
  • •renal or hepatic disease,
  • •acute limb ischemia,
  • •prior surgical bypass or angioplasty (with or without stent) on the target artery,
  • •obstructive disease (stenosis> 50%) of the aortoiliac segment ipsilateral to the target (if the aortoiliac is pre-treated, the patient may be included)

研究组 & 干预措施

Drug Eluting Balloon

Active Comparator

Admiral In.Pact Drug Eluting Balloon

干预措施: Drug Eluting Balloon Angioplasty (Device)

Nitinol Stent

Active Comparator

Complete SE Self-expandible Nitinol stent

干预措施: Nitinol stenting (Device)

结局指标

主要结局

Primary patency

时间窗: 12 months

Evaluations will be conducted after 3, 6 and 12 months of the procedure. The ultrasonographic evaluation of the degree of stenosis will use the Systolic Velocity Index (division of the velocity of flow at the point of greatest stenosis by the velocity of flow in normal prior segment). Rates higher than 2.4 indicate stenosis greater than 50%

次要结局

  • Acute myocardial infarct(12 months)
  • Death(12 months)
  • Ankle braquial Index(12 months)
  • Target Lesion Revascularization(12 months)
  • Rutherford classification(12 months)
  • Stent fracture(12 months)
  • Amputation(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fabio H Rossi

MD, PHD

Instituto Dante Pazzanese de Cardiologia

研究点 (1)

Loading locations...

相似试验